Biogen (BIIB) Restructuring Costs (2010 - 2026)
Biogen (BIIB) posted quarterly Restructuring Costs of $165.4 million for Q2 2026, up 23728.57% year-over-year from N/an in Q2 2025, and up 1993.67% quarter-over-quarter from $7.9 million in Q1 2026.
Biogen (BIIB) Restructuring Costs (2010 - 2026) Analysis & Trends
Biogen's Restructuring Costs history runs 13 years deep, the most recent figure standing at $165.4 million for Q2 2026.
- In Q2 2026, Restructuring Costs rose 23728.57% year-over-year to $165.4 million; the TTM figure through Jun 2026 stood at $187.3 million (up 301.07% YoY), while the FY2025 annual figure was $48.6 million, up 60.93% from the prior year.
- Restructuring Costs for Q2 2026 stood at $165.4 million, up from $7.9 million in the prior quarter.
- The five-year high for Restructuring Costs was $900.0 million in Q2 2022, with the low at -$700000.0 in Q2 2025.
- The 5-year median for Restructuring Costs is $7.6 million (2025), against an average of $73.8 million.
- The sharpest annual moves came in 2025 and 2026: Restructuring Costs sank 110.61% in 2025, then soared 23728.57% in 2026.
- Biogen's Restructuring Costs stood at $7.0 million in 2022, then soared by 1311.43% to $98.8 million in 2023, then plunged by 94.64% to $5.3 million in 2024, then rose by 24.53% to $6.6 million in 2025, then surged by 2406.06% to $165.4 million in 2026.
- Business Quant data shows BIIB's Restructuring Costs at $165.4 million in Q2 2026, $7.9 million in Q1 2026, and $6.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.37 Bn | 632.61 Bn | 17.26 Bn |
| 2 | AbbVie | 469.99 Bn | 463.42 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.26 Bn | 295.57 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.45 Bn | 252.55 Bn | 12.86 Bn |
| 6 | Amgen | 236.73 Bn | 222.74 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.06 Bn | 178.88 Bn | 6.22 Bn |
| 8 | Pfizer | 159.32 Bn | 147.62 Bn | 10.94 Bn |
| 9 | Gsk | 106.03 Bn | 101.87 Bn | 8.24 Bn |
| 10 | Biogen | 32.06 Bn | 30.77 Bn | 1.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 165.40 Mn |
| Mar 31, 2026 | 7.90 Mn |
| Dec 31, 2025 | 6.60 Mn |
| Sep 30, 2025 | 7.40 Mn |
| Jun 30, 2025 | -700,000.00 |
| Mar 31, 2025 | 35.30 Mn |
| Dec 31, 2024 | 5.30 Mn |
| Sep 30, 2024 | 6.80 Mn |
| Jun 30, 2024 | 6.60 Mn |
| Mar 31, 2024 | 11.50 Mn |
| Dec 31, 2023 | 98.80 Mn |
| Sep 30, 2023 | 11.50 Mn |
| Jun 30, 2023 | 17.80 Mn |
| Mar 31, 2023 | 7.10 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Sep 30, 2022 | 7.10 Mn |
| Jun 30, 2022 | 900.00 Mn |
| Mar 31, 2022 | 27.70 Mn |
| Sep 30, 2019 | 300,000.00 |
| Jun 30, 2019 | 800,000.00 |